Literature DB >> 6973823

Preferential synthesis of the G1m(1) allotype of IgG1 in the central nervous system of multiple sclerosis patients.

J P Salier, J M Goust, J P Pandey, H H Fudenberg.   

Abstract

Quantitations of the G1m(1) and G1m(3) allotypic determinants of human immunoglobulin G were performed by radioimmunoassay on cerebrospinal fluid and serum samples from patients with multiple sclerosis and from patients with other neurological disorders. In multiple sclerosis patients that were heterozygous for these determinants, G1m(1) concentration in the cerebrospinal fluid was greatly increased-reflected by an increased ratio of G1m(1)-in comparison with that of patients with other neurological disorders. These results suggest that in the heterozygous multiple sclerosis patients, most of the plasma cells in the central nervous system that secrete oligoclonal immunoglobulin G preferentially synthesize G1m(1) IgG1 molecules.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973823     DOI: 10.1126/science.6973823

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

1.  Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism.

Authors:  C N Gaiser; M J Johnson; G de Lange; L Rassenti; L L Cavalli-Sforza; L Steinman
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

2.  Immunoglobulin G in multiple sclerosis brain.

Authors:  T Hosokawa; J C Hunt; J J Marchalonis; E L Hogan
Journal:  Metab Brain Dis       Date:  1988-09       Impact factor: 3.584

3.  Local and systemic immune response in multiple sclerosis: analysis of CSF inflammatory changes and peripheral blood T-cell subsets.

Authors:  A J Steck; J C de Flaugergues
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

Review 4.  The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis.

Authors:  K C O'Connor; A Bar-Or; D A Hafler
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

5.  Distribution of nominal and latent IgG (Gm) allotypes in plaques of multiple sclerosis brain.

Authors:  J P Salier; P Glynn; J M Goust; M L Cuzner
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

6.  Human immunoglobulin allotypes: previously unrecognized determinants and alleles defined with monoclonal antibodies.

Authors:  D Zelaschi; C Newby; M Parsons; B van West; L L Cavalli-Sforza; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

7.  Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis.

Authors:  Andreas Lossius; Alina Tomescu-Baciu; Trygve Holmøy; Christian A Vedeler; Egil Røsjø; Åslaug R Lorentzen; Ilaria Casetta; Frode Vartdal
Journal:  Ann Clin Transl Neurol       Date:  2017-09-27       Impact factor: 4.511

8.  The forgotten tale of immunoglobulin allotypes in cancer risk and treatment.

Authors:  Janardan P Pandey; Zihai Li
Journal:  Exp Hematol Oncol       Date:  2013-02-20

9.  G1m1 predominance of intrathecal virus-specific antibodies in multiple sclerosis.

Authors:  Alina Tomescu-Baciu; Frode Vartdal; Trygve Holmøy; Christian A Vedeler; Andreas Lossius
Journal:  Ann Clin Transl Neurol       Date:  2018-09-17       Impact factor: 4.511

Review 10.  Multiple sclerosis: neuroimmunologic puzzle.

Authors:  B P Barna
Journal:  Clin Lab Med       Date:  1986-03       Impact factor: 1.935

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.